1. The Research Status and Cardiovascular Ad-verse Reactions of Antiangiogenic Drugs
   丽婷 胡, 2023, Advances in Clinical Medicine CrossRef
2. Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
   Mo-Yun Li et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
3. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
   Sunitha Shyam Sunder et al, 2023, Signal Transduction and Targeted Therapy CrossRef
4. The interaction between PAX9 rs2073244 and passive smoking during pregnancy on low birth weight in newborns: a case–control study
   Qun Lou et al, 2024, International Journal of Environmental Health Research CrossRef
5. The Role of Pharmacogenomics in Drug-Induced Cardiovascular Toxicity
   Ranko Škrbić et al, 2024, Environmental Factors in the Pathogenesis of Cardiovascular Diseases CrossRef
6. Major adverse cardiovascular events of vascular endothelial growth factor tyrosine kinase inhibitors among patients with different malignancy: A systemic review and network meta-analysis
   Yen-Chou Chen et al, 2024, Journal of the Chinese Medical Association CrossRef
7. The Role of Genome-Wide Association Study in Pulmonary Disease Diagnostics: A Review in Medical Bioinformatics
   Rossalyn Andromeda et al, 2024, Jurnal Respirasi CrossRef